4//SEC Filing
FAMBROUGH DOUGLAS 4
Accession 0001399529-21-000162
CIK 0001399529other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 7:33 PM ET
Size
10.3 KB
Accession
0001399529-21-000162
Insider Transaction Report
Form 4
FAMBROUGH DOUGLAS
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-10$2.97/sh+33,670$100,000→ 76,834 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-12-10−146,195→ 55,055 totalExercise: $3.42Exp: 2023-09-24→ Common Stock (146,195 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-12-10−33,670→ 191,330 totalExercise: $2.97Exp: 2027-01-03→ Common Stock (33,670 underlying) - Exercise/Conversion
Common Stock
2021-12-10$3.42/sh+146,195$499,987→ 223,029 total
Footnotes (2)
- [F1]As of the transaction date, the option was fully vested. The option vested in 48 monthly installments over the four-year period starting on the last day of January 2017.
- [F2]As of the transaction date, the option was fully vested. The option vested 1/48 monthly on last day of each month with a vesting start date of 07/30/2013.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001259856
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 7:33 PM ET
- Size
- 10.3 KB